Cite
HARVARD Citation
Grossberg, G. et al. (n.d.). P3–273: Efficacy, safety and tolerability of a higher‐dose 13.3 mg/24 h rivastigmine patch in people with severe Alzheimer's disease with and without concomitant memantine use. Alzheimer's & dementia. p. P656. [Online].